Prediction of pulmonary tuberculosis treatment outcome in a sub‑Saharan African context


  • Joseph Magloire Fossokeng Mouafo University of Douala
  • André Nana Yakam University of Douala
  • Claude Simo University of Douala
  • Jules Sadefo Kamdem University of Montpellier
  • Samuel Bowong
  • Louis Aimé Fono University of Douala
  • Jürgen Noeske Independant Consultant, Yaounde



Scoring method, logistic regression, tuberculosis, treatment failure, Cameroon


Background: Failure to treat many pathogens is a concern. Identifying a priori, patients with potential failure treatment outcome of a disease could allow measures to reduce the failure rate. Objective: The objectives of this study were to use the Scoring method to identify factors associated with the tuberculosis unsuccessful treatment outcome and to predict the treatment outcome. Methods: A total of 1,529 patients with pulmonary tuberculosis were randomly selected in the city of Douala, Cameroon, this sample was randomly split into two parts: one subsample of 1,200 patients (78%) used as the Development sample, and the remaining of 329 patients (22%) used as the Validation sample. Baseline characteristics associated with unsuccessful treatment outcomes were investigated using logistic regression. The optimal score was based on the Youden’s index. Results: HIV positive status, active smoker and non-belief in healing were the factors significantly associated with unsuccessful treatment outcomes (p < 0.05). A model used to estimate the risk of unsuccessful treatment outcome was derived. The threshold probability which maximize the area under the ROC curve was 18%. Patients for whom the risk was greater than this threshold were classified as unsuccessful treatment outcome and the others as successful. HIV positive and active smoking status were associated with death; the non-belief in healing, youth and male gender associated with lost-to-follow-up, TB antecedent and not having TB contact associated with therapeutic treatment failure. Conclusion: To increase the tuberculosis treatment success rate, targeted follow-up could be taken during the treatment for TB patients with previous characteristics.

Download data is not yet available.


(1) World Health Organization, Global tuberculosis report, 2014, WHO/HTM/TB/2015.22. Geneva, Switzerland: WHO; 2015.

(2) WHO, Antibacterial agents in clinical development an analysis of the antibacterial clinical development pipeline, including tuberculosis; 2017.

(3) Bending the curve ending TB: Annual report 2017. India: World Health Organization, Regional Office for South East Asia; 2017. Licence: CC BYNCSA 3.0 IGO.

(4) W.H.O., Global tuberculosis report 2022: Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0

(5) IGO. (accessed on 10 May 2022)

(6) Noeske J., Nana Yakam A., Abena Foe J.L., Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 20062014, Int J Tuberc Lung Dis 2016; 20 :1489-1494. DOI:

(7) World Health Organization, GLOBAL TUBERCULOSIS REPORT 2016,

(8) Pablos Mendez A. Paviglione MC, LaszLo A et al. Global surveillance for antituberculosis drug resistance 1994-1997. N Engl J Med 1998; 338:1641-49. DOI:

(9) World Health Organization. Revised TB recording and reporting forms and registers: version 2006.WHO/HTM/TB/2006.373. Geneva, Switzerland: WHO, 2006.

(10) Hosmer D, Lemeshow S. Applied logistic regression. 2nd ed. New York: Willey; 2000. DOI:

(11) Collett D. Modelling binary data. 2nd ed. New York: Chapman & Hall/CRC; 2003. DOI:

(12) Youden W J, Index for rating diagnostic tests, Cancer 1950, 3:32-5. DOI:<32::AID-CNCR2820030106>3.0.CO;2-3

(13) Elnazeer A. A. H. and Elsadig Y. M., Risk Factors for Default from Tuberculosis (TB) Treatment in Patients Attending a Rural Sudanese Hospital. EC Pulmonology and Respiratory Medicine 2017; 3.6: 177-182.

(14) A. Finlay, J. Lancaster, T. H. Holtz, et al., Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case control study, BMC Public Health 2012; 12:56, DOI:

(15) G. Berhe, F. Enquselassie, A. Aseffa, Treatment outcome of smear positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia, BMC Public Health 2012; 12:537, DOI:

(16) Vijay S, Kumar P, Chauhan LS, et al., Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India. PLoS ONE 2010; 5: e10043. doi: 10.1371/journal.pone.0010043 DOI:

(17) Horita N, Miyazawa N, Yoshiyama T et al., Development and validation of a tuberculosis prognostic score for smear positive inpatients in Japan INT J TUBERC LUNG DIS 2013; 17:54-60 DOI:

(18) Pefura Yone E W, Balkissou A D, Poka Mayap V et al., Development and validation of a prognostic score during tuberculosis treatment, BMC Infectious Diseases 2017;17:251 DOI:

(19) Enarson D.A., Wang J.S., Dirks J.M. The incidence of active tuberculosis in a large urban area, Am J Epidemiol 1989;129: 1268-76. DOI:

(20) Tour´e NO, Dia Kane Y, Diatta A, et al., Tuberculose du sujet ˆag´e, Revue des Maladies Respiratoires 2010; 27:1062-1070 DOI:

(21) Abdallah T M and Ali A A A , Epidemiology of tuberculosis in Eastern Sudan, Asian Pac J Trop Biomed.2012; 2: 999-1001. DOI:

(22) Yen YF, Yen MY, Shih HC et al. Prognostic factors associated with mortality before and during anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2013; 17:1310–6. DOI:

(23) Babalik A, Kilicaslan Z, Sevkan Caner S et al. A registry-based cohort study of pulmonary tuberculosis treatment outcomes in Istanbul, Turkey. Jpn J Infect Dis. 2013; 66:115–20. DOI:

(24) Yen YF, Yen MY, Shih HC, Deng CY. Risk factors for unfavorable outcome of pulmonary tuberculosis in adults in Taipei, Taiwan. Trans R Soc Trop Med Hyg. 2012; 106:303–8 DOI:

(25) Horne DJ, Hubbard R, Narita M et al. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis. 2010; 10:258. DOI:

(26) Pardeshi G. Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course. Indian J Med Sci. 2009; 63:180–6. DOI:

(27) Alobu I, Oshi SN, Oshi DC, Ukwaja KN. Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting. Asian Pac J Trop Med. 2014; 7:977–84. DOI:

(28) Choi H, Lee M, Chen RY et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005–2012. BMC Infect Dis. 2014; 14:360. DOI:

(29) Aubry P, Bernard-Alex G, Tuberculose Actualit´es 2018, M´edecine Tropicale 2018,

(30) Franz, J., L., Veronique, D., Thomas, D., A color Atlas of comparative pathology of pulmonary tuberculosis. CRC press ;2010.

(31) Török M.E., Farrar J.J., When to start antiretroviral therapy in HIV-associated tuberculosis, N Engl J Med 2011; 365: 1538-1540. DOI:




How to Cite

Fossokeng Mouafo, J. M., Nana Yakam, A., Simo, C., Sadefo Kamdem, J., Bowong, S., Fono, L. A., & Noeske, J. (2023). Prediction of pulmonary tuberculosis treatment outcome in a sub‑Saharan African context. Journal of Public Health in Africa, 14(10).



Original Articles